Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04131023 · ClinicalTrials.gov registry record · NA
Metabolic Tracking and Weight Gain During Pregnancy
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT04131023: Completed NA study, sponsored by Arizona State University.
NCT04131023 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04131023, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
In this study, the investigators aimed to have pregnant women use a hand-held device to track increases in daily caloric needs during pregnancy. Weight gain was assessed over time with the goal of reducing excessive gestational weight gain relative to a group of pregnant women who received standard prenatal care.
Primary Outcome
Change in body weight from study baseline to 13 weeks
Interventions
- BEHAVIORAL Breezing Metabolic Rate Tracking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2017-09-17 |
| Est. Completion | 2018-11-01 |
| Phase | NA |
What the finished NCT04131023 record still lists
NCT04131023 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Breezing Metabolic Rate Tracking is the first listed.
NCT04131023 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04131023 about?
NCT04131023 is a clinical study titled "Metabolic Tracking and Weight Gain During Pregnancy". In this study, the investigators aimed to have pregnant women use a hand-held device to track increases in daily caloric needs during pregnancy. Weight gain was assessed over time with the goal of reducing excessive gestational weight gain relative to a group of pregnant women who received standard ...
What is the current status of trial NCT04131023?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2017-09-17. Estimated completion is 2018-11-01.
What interventions are being tested in trial NCT04131023?
The interventions under investigation include: Breezing Metabolic Rate Tracking (BEHAVIORAL).
Who is sponsoring clinical trial NCT04131023?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04131023's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI